Chalela, R.; Bellosillo, B.; Curull, V.; Longarón, R.; Pascual-Guardia, S.; Badenes-Bonet, D.; Arriola, E.; Sánchez-Font, A.; Pijuan, L.; Gea, J.
EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma. J. Clin. Med. 2019, 8, 529.
https://doi.org/10.3390/jcm8040529
AMA Style
Chalela R, Bellosillo B, Curull V, Longarón R, Pascual-Guardia S, Badenes-Bonet D, Arriola E, Sánchez-Font A, Pijuan L, Gea J.
EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma. Journal of Clinical Medicine. 2019; 8(4):529.
https://doi.org/10.3390/jcm8040529
Chicago/Turabian Style
Chalela, Roberto, Beatriz Bellosillo, VÃctor Curull, Raquel Longarón, Sergi Pascual-Guardia, Diana Badenes-Bonet, Edurne Arriola, Albert Sánchez-Font, Lara Pijuan, and Joaquim Gea.
2019. "EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma" Journal of Clinical Medicine 8, no. 4: 529.
https://doi.org/10.3390/jcm8040529
APA Style
Chalela, R., Bellosillo, B., Curull, V., Longarón, R., Pascual-Guardia, S., Badenes-Bonet, D., Arriola, E., Sánchez-Font, A., Pijuan, L., & Gea, J.
(2019). EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma. Journal of Clinical Medicine, 8(4), 529.
https://doi.org/10.3390/jcm8040529